Hologic HOLX

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. Review of long-term mammogram data shows a reduction in breast cancer deaths


      Wed, 2 Apr 2014

      term Canadian study that found that yearly mammograms did not reduce the chance of a woman would die of breast cancer and confirmed that many detected abnormalities would not have been fatal if left untreated. ( HOLX ) Post your comment!

    2. Deep Value In This Diagnostic Company Might Attract Activists


      Thu, 27 Mar 2014

      By Paul Nouri, CFP : Despite 2013 being one of the best years for IPO's in recent memory, shares of Liposcience ( LPDX ), which went public at $9, quickly rose to $11 only to plummet to $4 by the end of the year. The company faced challenges on many different fronts in 2013. After a profitable ...

    3. CORRECTED-Medical device maker Hologic names ex-J&J exec to new COO post


      Fri, 14 Mar 2014

      (Corrects paragraph 1 to "striking a deal" from "as part of a deal" and paragraph 8 to drop "hiring of MacMillan")

    4. Hologix announces leadership changes


      Fri, 14 Mar 2014

      Hologix ( HOLX ) appoints Eric Compton Chief Operating Officer . Claus Egstrand named Senior Vice President and General Manager of the company

    5. Hologic's First-Quarter Earnings in Line With Expectations; Reaffirms 2014 Forecast


      Tue, 4 Feb 2014

      Hologic reported first-quarter earnings on Monday ..... necessary step toward broadening the appeal of Hologic 's equipment. Adjusted gross margins ..... Despite an uptick in administrative costs, Hologic kept overall operating expenses in check

    6. New Morningstar Analyst Report for Alere Inc

      Stock Reports

      Tue, 28 Jan 2014

      general, and administrative leverage as Alere integrates acquired businesses. Lastly, recent M&A activity in diagnostics-- Hologic 's acquisition of Gen-Probe, Roche's attempted takeover of Illumina--could be an impetus for other companies to pursue

    7. New Morningstar Analyst Report for Abbott Laboratories

      Stock Reports

      Tue, 21 Jan 2014

      diagnostics arena where it must go head-to-head against market leader Roche, along with energetic upstarts like Qiagen and Hologic .Considering the heterogeneity involved in mitral valve disease, we are skeptical MitraClip will move beyond niche use for

    8. History Could Repeat Itself At Hologic


      Thu, 9 Jan 2014

      SkyTides : The current state of Hologic ( HOLX ) is summed up well by Amit Hazan ..... This article will explain how Hologic has destroyed shareholder value ..... if an investor is still long Hologic , they need to consider whether

    9. New Morningstar Analyst Report for Hologic Inc

      Stock Reports

      Fri, 20 Dec 2013

      screening intervals and could weigh on Hologic ’s results past 2014 should it take longer ..... for approval remains uncertain.Despite Hologic ’s full pipeline and best efforts, a ..... consuming, and fruitless process. Hologic currently manufacturers the only FDA approved

    10. Hologic names new CEO, adds two Icahn nominees to board


      Mon, 9 Dec 2013

      (Reuters) - Medical device maker Hologic Inc named a former Stryker Corp CEO as its chief executive, and said it appointed two directors backed by Carl Icahn to its board as part of a settlement with...

    « Prev12345Next »
    Content Partners